Oxymetholone

Janessa Smith, Pharm.D. BCPS, Paul A. Pham, Pharm.D.

INDICATIONS

FDA

  • Acquired aplastic anemia (only moderately effective; erythropoietin preferred)
  • Anemia-associated with chronic renal failure
  • Chemotherapy-induced myleosuppression
  • Fanconi’s anemia
  • Red cell aplasia

NON-FDA APPROVED USES

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: December 4, 2016